NOW APPROVED PREVYMIS TM (letermovir) 240 mg, 480 mg tablets Injection 20 mg/mL Visit Booth #1633 Learn more at www.prevymis.com/hcp Copyright © 2017 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved. AINF-1219179-0000 11/17